Liver Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 21, 2005; 11(7): 943-947
Published online Feb 21, 2005. doi: 10.3748/wjg.v11.i7.943
Figure 3
Figure 3 SWE induces the activation of caspase-3 and PARP cleavage in HepG2 cells. A: HepG2 cells (1.5×107) treated with 0-5.0 mg/mL of SWE for 24 h; B and C: HepG2 cells treated with 2.0 mg/mL SWE for the indicated time periods. aP<0.05, bP<0.01 vs control.